ClinConnect ClinConnect Logo
Search / Trial NCT06836622

Carotid-Femoral, Oscillometric and Estimated Pulse Wave Velocity

Launched by HOSPITAL DE BASE · Feb 15, 2025

Trial Information

Current as of July 01, 2025

Enrolling by invitation

Keywords

Arterial Stiffness Hypertension Pulse Wave Velocity

ClinConnect Summary

•BACKGROUND It is estimated that 1 in 4 adults suffers from hypertension, including 40% of those over the age of 25. Blood pressure tends to be higher in older adults, and in developed countries, an estimated 9 in 10 adults who live to 80 years of age will develop hypertension. Over the decades, data have shown a positive and continued association between BP values and the occurrence of heart attacks and strokes.

Artery stiffening (AS) and increased pulsatile diameter were identified as standard features of hypertension in individuals aged between 40 and 50 years, and have emerged as two o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria :
  • - Individuals older than 18 with an elevated office blood pressure :
  • suspected hypertension diagnosis or
  • uncontrolled hypertension under treatment
  • Exclusion Criteria:
  • 24-hour ABPM recordings presenting:
  • less than 70% of the expected measurements or
  • fewer than 20 valid awake or seven valid sleeping measurements or
  • fewer than two valid daytime and one valid night-time measurement per hour

About Hospital De Base

Hospital de Base is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through rigorous clinical trials. With a strong focus on innovation and safety, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct a wide range of studies across various therapeutic areas. Committed to ethical standards and regulatory compliance, Hospital de Base fosters collaborations with academic institutions and industry partners to facilitate the development of cutting-edge therapies, ultimately enhancing the quality of care for its diverse patient population.

Locations

Uberaba, Minas Gerais, Brazil

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported